Gemzar Paragraph IV Certification Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for Lilly's oncologic Gemzar (gemcitabine) was filed Nov. 1, according to FDA's Jan. 3 updated list of filings